Skip to Main Content

Paper Details

Identification of the global miR-130a targetome reveals a role for TBL1XR1 in hematopoietic stem cell self-renewal and t(8;21) AML.
Cell Rep
4
2022
-, AML, AML1, ETO, HSC, HSCs, TBL1XR1, acute myeloid leukemia, chimeric AGO2, hematopoietic stem cell, hematopoietic stem cells, long-term HSCs, mRNA, malignant, miR, miR-130a, miR-130a targetome, miRNA, microRNAs, normal, normal and leukemic cells, primary cells, t(8, t(8;21), t(8;21) AML
Author NameAffiliation
Alex MurisonPrincess Margaret Cancer Centre, University Health Network
Stefan AignerUniversity of California
Eric L Van NostrandUniversity of California
Eric L Van NostrandUniversity of California
Daniel D De CarvalhoPrincess Margaret Cancer Centre, University Health Network, University of Toronto
Gary D BaderPrincess Margaret Cancer Centre, University Health Network, University of Toronto
Gene W YeoUniversity of California
Gene W YeoUniversity of California
John E DickPrincess Margaret Cancer Centre, University Health Network, University of Toronto
  • 1 - 9

Datasets

Release 1.2